Tag Archives: Barry S. Coller

Rockefeller University awarded $27 million NIH grant to fund clinical and translational science in Hospital

The five-year “CTSA” grant will enable clinical work based at The Rockefeller University Hospital. The Clinical and Translational Science Award, given by the NIH, is designed to improve the translational research process and foster innovation in research methods, training, and career development. More »

Tags: , , , , ,

Barry Coller receives the 2016 Gill Award for outstanding contributions to cardiovascular research

Barry Coller receives the 2016 Gill Award for outstanding contributions to cardiovascular researchThis award, given by the University of Kentucky Gill Heart Institute, honors Coller for work that has made a lasting impact on the understanding of cardiovascular biology and disease. Coller studies molecular interactions between blood cells and blood vessels, as well as therapies for diseases such as heart attack and stroke. More »

Tags: , , , , , ,

Helmsley Trust renews $15 million grant for novel digestive disorders research

Helmsley Trust renews $15 million grant for novel digestive disorders research The funding renewal will support research initiatives within Rockefeller’s interdisciplinary Center for Basic and Translational Research on Disorders of the Digestive System. The center brings together about 20 labs that study a broad range of biological processes related to the digestive system. More »

Tags: , , , , , ,

In the News – Washington Post

New ‘cool videos’ from NIH look at Alzheimer’s, heart attacks, MS, coral reefs   “A ‘stop heart attack’ refrain echoes through Rockefeller University’s ‘molecular biomedicine music video’ featuring some flashy animation and seriously geeky dancing.”

Tags:

Large-scale survey of clinical research participants shows mostly positive experiences

Although many participants gave high marks to the research teams’ trustworthiness and ability to explain their protocols, the survey also revealed that a sizable minority did not feel completely prepared for the study. The results suggest aspects of the participant experience that researchers may be able to address. More »

Tags: ,

Rockefeller University receives $36.1 million to help translate science into cures

Rockefeller University’s Center for Clinical and Translational Science (CCTS), a center aimed at accelerating the pace of translating science into real-life solutions for patients, has received $36.1 million from the National Institutes of Health to expand its work over the next five years. The CCTS is among 10 institutes nationwide to receive the renewed funding, in recognition of their successes during the first five years of the NIH’s Clinical and Translational Science Awards program. More »

Tags: , ,

Rockefeller joins Pfizer’s Global Centers For Therapeutic Innovation

A new partnership will mimic a venture capital-funded biotechnology start-up model, whereby Pfizer funds pre-clinical and clinical development programs in return for the opportunity to potentially broaden its pipeline with novel and highly differentiated candidate drugs. More »

Tags: ,

Rockefeller joins first national research study recruitment registry

Rockefeller University has joined more than 50 U.S. research institutions in making information about its clinical research trials available on ResearchMatch, the country’s first registry for recruiting research participants. The secure Web site offers a free and safe way for volunteers to connect with thousands of researchers who are conducting research on a wide range of diseases. More »

Tags: , ,

New clinical study will help doctors assess abnormal bleeding

A new assessment tool being tested at The Rockefeller University Hospital may help physicians and researchers more accurately determine what is inside and outside the normal range of bleeding symptoms. More »

Tags: ,

New molecule could be key to new anti-heart-attack drug

New research suggests that it should be possible to create a clot-busting pill that targets blood cells called platelets — something that high-risk patients could take at the first sign of chest pain, saving previous time and preventing excess damage. More »

Tags: ,

Help for bleeding hearts: new research links a third protein to blood-clotting disorders

Analyzing patients with a rare blood disorder led Rockefeller scientists to discover that a protein called calnexin is required to build a blood-cell receptor that’s required for clotting. More »

Tags: , , ,